Azafaros is based in Basel, Switzerland. It has raised $150M in total funding. Latest round: Series B.
Azafaros funding overview
Azafaros is based in Basel, Switzerland. Azafaros has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2025. The round record for Azafaros runs through 2025; nothing later has been disclosed. Investors on record include Forbion, BioGeneration Ventures, BioMedPartners, Asahi Kasei Pharma Ventures, Schroders Capital, Jeito and 1 others. 7 distinct backers are named across the disclosed rounds.
Azafaros has raised $150M in total disclosed funding across the rounds on record.
Who has invested in Azafaros?
Forbion, BioGeneration Ventures, BioMedPartners, Asahi Kasei Pharma Ventures, Schroders Capital, Jeito are named among the investors backing Azafaros.
What was the latest Azafaros funding round?
The most recent disclosed round is a Series B, announced in May 2025.
Where is Azafaros based?
Azafaros is based in Basel, Switzerland.
When did Azafaros last raise?
The last disclosed Azafaros round closed in May 2025 at Series B.
Totals shown for Azafaros aggregate every disclosed round on file. To see how that compares, browse the companies in Basel and the investors behind them below.
